Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial

INTRODUCTION: To compare the efficacy and tolerability of dapagliflozin with those of sitagliptin and metformin in patients with type 2 diabetes who have never received glucose-lowering agents. METHODS: In this randomized, 12-week, open-label, active-controlled trial, 32 patients were randomly assig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Daisuke, Inoue, Kazuyuki, Saito, Daigo, Hamaguchi, Keiko, Kaneko, Kimie, Sumita, Takashi, Inukai, Kouichi, Inoue, Ikuo, Shimada, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586398/
https://www.ncbi.nlm.nih.gov/pubmed/34709582
http://dx.doi.org/10.1007/s13300-021-01176-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586398/
https://www.ncbi.nlm.nih.gov/pubmed/34709582
http://dx.doi.org/10.1007/s13300-021-01176-x

Ejemplares similares